Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported.

Blood advances - 14 Dec 2021

Anekpuritanang Tauangtham, Klairmont Matthew M, Gradowski Joel, Hagiwara Kohei, Bailey Nathanael G, Chandra Pranil, Liu Yiwei, Mulder Heather L, Easton John, Zhang Jinghui, Martin Michael G, Owczarczyk Anna B, Dunlap Jennifer B, Fan Guang, Press Richard D, Raess Philipp W

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cohort Studies
Share to Mutation
Share to Prevalence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Open in PubMed Open full text

Identifiers

PMID: 34559205
DOI: 10.1182/bloodadvances.2021004983
PMCID: PMC9152993

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported.PMID 34559205Read ↗

Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms.Semantic proximity Read ↗

Describing the Mutational Characteristics of Myxofibrosarcoma: An AACR Project GENIE Analysis.Semantic proximity Read ↗

Isolated myelosarcoma is characterized by recurrent NFE2 mutations and concurrent preleukemic clones in the bone marrow.Semantic proximity Read ↗

Biology and Management of High-Grade Myxofibrosarcoma: State of the Art and Future PerspectivesSemantic proximity Read ↗

NF1 glioblastoma clonal profiling reveals KMT2B mutations as potential somatic oncogenic events.Semantic proximity Read ↗

Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrationsSemantic proximity Read ↗

Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic targetSemantic proximity Read ↗

Molecular and clinical characterization of ETNK1-mutated myeloid neoplasms: the Mayo Clinic experience.Semantic proximity Read ↗

Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children’s Oncology GroupSemantic proximity Read ↗

NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome.Semantic proximity Read ↗

Subtype-Specific Patterns of Tumor Purity and Mutation Load Suggest Treatment Implications: A Cross-Sectional Analysis of 7494 Soft Tissue and Bone Sarcomas (MSK Cohort).Semantic proximity Read ↗

Clinicopathologic Features of a Second Patient With Ewing-like Sarcoma Harboring CIC-FOXO4 Gene FusionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.